119 related articles for article (PubMed ID: 9855029)
1. Existing treatment strategies: does noncompliance make a difference?
Caro JJ; Speckman JL
J Hypertens Suppl; 1998 Sep; 16(7):S31-4. PubMed ID: 9855029
[TBL] [Abstract][Full Text] [Related]
2. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.
Caro JJ; Speckman JL; Salas M; Raggio G; Jackson JD
CMAJ; 1999 Jan; 160(1):41-6. PubMed ID: 9934342
[TBL] [Abstract][Full Text] [Related]
3. Stepped care for hypertension: are the assumptions valid?
Caro JJ
J Hypertens Suppl; 1997 Dec; 15(7):S35-9. PubMed ID: 9532519
[TBL] [Abstract][Full Text] [Related]
4. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study.
Bourgault C; Sénécal M; Brisson M; Marentette MA; Grégoire JP
J Hum Hypertens; 2005 Aug; 19(8):607-13. PubMed ID: 15920457
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
7. Long-term persistence with antihypertensive drugs in new patients.
Degli Esposti E; Sturani A; Di Martino M; Falasca P; Novi MV; Baio G; Buda S; Volpe M
J Hum Hypertens; 2002 Jun; 16(6):439-44. PubMed ID: 12037702
[TBL] [Abstract][Full Text] [Related]
8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
10. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
Pikilidou MI; Lasaridis AN; Sarafidis PA; Tziolas IM; Zebekakis PE; Dombros NV; Giannoulis E
Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
Linjer E; Hedner T; Jönsson B; Ekbom T; Lindholm LH; Dahlöf B; de Faire U; Scherstén B;
Blood Press; 2005; 14(2):107-13. PubMed ID: 16036488
[TBL] [Abstract][Full Text] [Related]
13. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
14. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
[TBL] [Abstract][Full Text] [Related]
15. [Combined antihypertensive therapy: review of multicenter studies conducted in foreign countries].
Shabalin AV; Nikitin IuP
Ter Arkh; 1999; 71(8):74-8. PubMed ID: 10515043
[No Abstract] [Full Text] [Related]
16. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
Cardinal H; Monfared AA; Dorais M; LeLorier J
Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
[TBL] [Abstract][Full Text] [Related]
17. Optimizing hypertension management in clinical practice.
Heagerty A
J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
[TBL] [Abstract][Full Text] [Related]
18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
19. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
20. Choice of initial antihypertensive medication and continuation of use.
Grégoire JP
Can J Cardiol; 1999 Nov; 15 Suppl F():39F-41F. PubMed ID: 10579751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]